{
    "code": "02025183",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025183",
    "time": "2016-05-27 03:27:21",
    "許可證字號": "衛署藥輸字第025183號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/05\/11",
    "發證日期": "99\/05\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202518302",
    "中文品名": "健達必凍晶注射劑",
    "英文品名": "DBL Gemcitabine For Injection",
    "適應症": "非小細胞肺癌、胰臟癌、膀胱癌、GEMCITABINE與PACLITAXEL併用，可使用於曾經使用過ANTHRACYCLINE之局部復發且無法手術切除或轉移性之乳癌病患。用於曾經使用含鉑藥物(PLATINUM-BASED)治療後復發且間隔至少6個月之卵巢癌，作為第二線治療。",
    "劑型": "243凍晶注射劑",
    "包裝": "200毫克小瓶裝 1公克小瓶裝 2公克小瓶裝 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "GEMCITABINE HYDROCHLORIDE",
    "限制項目": [
        "02輸入",
        "24監視期滿學名藥"
    ],
    "申請商名稱": "620102S342  新加坡商赫士睿股份有限公司台灣分公司",
    "申請商地址": "新北市淡水區中正東路2段177號",
    "主製造廠": {
        "製造廠名稱": "F020031100  HOSPIRA AUSTRALIA PTY LTD.",
        "製造廠廠址": "1-5, 7-23 AND 25-39 LEXIA PLACE, MULGRAVE, VICTORIA 3170, AUSTRALIA",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "1225204000  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平村1鄰舊厝子1之2號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "(Equiva. Gemcitabine 200mg)",
            "含量": "228.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "(Equiva. Gemcitabine 1g)",
            "含量": "1.1400000000",
            "單位": "GM"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1010000610",
            "成分名稱": "GEMCITABINE HYDROCHLORIDE",
            "含量描述": "(Equiva. Gemcitabine 2g)",
            "含量": "2.2800000000",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "P2518301健達必凍晶注射劑Gemcitabine(36x52.4cm)-背面final-103-01-07.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025183&Seq=003&Type=9"
        },
        {
            "title": "P2518301健達必凍晶注射劑Gemcitabine(36x52.4cm)-正面final-103-01-07.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025183&Seq=002&Type=9"
        },
        {
            "title": "02025183仿單___20100707.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025183&Seq=001&Type=9"
        },
        {
            "title": "020251830022___20100707.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025183&Seq=003&Type=8"
        },
        {
            "title": "020251830021___20100707.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025183&Seq=002&Type=8"
        },
        {
            "title": "020251830020___20100707.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025183&Seq=001&Type=8"
        }
    ]
}